Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Liebman

Showing results (151-160 of 216) with videos related to

Pageof 22
Sort By:
Tropical Medicine & International Health : TM & IH|October 8, 2009
Shifting priorities in vector biology to improve control of vector-borne diseaseLouis Lambrechts, Tessa B Knox, Jacklyn Wong, et al.
Methods in Enzymology|January 1, 1979
The preparation of L-ascorbic acid [35S]2-sulfate having a high specific activityR R Muccino, R Markezich, G G Vernice, et al.
Blood|August 1, 1984
Comparison of the native prothrombin antigen and the prothrombin time for monitoring oral anticoagulant therapyB Furie, H A Liebman, R A Blanchard, et al.
Cancer|November 15, 1982
Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparinR M Sandler, H A Liebman, M J Patch, et al.
Parasites & Vectors|December 17, 2013
Molecular evidence for historical presence of knock-down resistance in Anopheles albimanus, a key malaria vector in Latin AmericaJuan C Lol, María E Castellanos, Kelly A Liebman, et al.
Thrombosis and Haemostasis|August 28, 2002
Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activationIlene C Weitz, Valerie K Israel, James R Waisman, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Restoring transient connectivity during development improves dysfunctions in fragile X miceDimitri Dumontier, Samuel A Liebman, Viet-Hang Le, et al.
American Journal of Hematology|February 19, 2000
Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIIIH A Liebman, J Chediak, K I Fink, et al.
Cancer|February 15, 1983
Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparinR M Sandler, H A Liebman, M J Patch, et al.
AJR. American Journal of Roentgenology|December 1, 1988
AIDS-related Kaposi sarcoma: findings on thallium-201 scintigraphyV W Lee, M P Rosen, A Baum, et al.
Pageof 22

Showing results (151-160 of 216) with videos related to

Sort By:
Pageof 22
Tropical Medicine & International Health : TM & IH|October 8, 2009
Shifting priorities in vector biology to improve control of vector-borne diseaseLouis Lambrechts, Tessa B Knox, Jacklyn Wong, et al.
Methods in Enzymology|January 1, 1979
The preparation of L-ascorbic acid [35S]2-sulfate having a high specific activityR R Muccino, R Markezich, G G Vernice, et al.
Blood|August 1, 1984
Comparison of the native prothrombin antigen and the prothrombin time for monitoring oral anticoagulant therapyB Furie, H A Liebman, R A Blanchard, et al.
Cancer|November 15, 1982
Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparinR M Sandler, H A Liebman, M J Patch, et al.
Parasites & Vectors|December 17, 2013
Molecular evidence for historical presence of knock-down resistance in Anopheles albimanus, a key malaria vector in Latin AmericaJuan C Lol, María E Castellanos, Kelly A Liebman, et al.
Thrombosis and Haemostasis|August 28, 2002
Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activationIlene C Weitz, Valerie K Israel, James R Waisman, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Restoring transient connectivity during development improves dysfunctions in fragile X miceDimitri Dumontier, Samuel A Liebman, Viet-Hang Le, et al.
American Journal of Hematology|February 19, 2000
Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIIIH A Liebman, J Chediak, K I Fink, et al.
Cancer|February 15, 1983
Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparinR M Sandler, H A Liebman, M J Patch, et al.
AJR. American Journal of Roentgenology|December 1, 1988
AIDS-related Kaposi sarcoma: findings on thallium-201 scintigraphyV W Lee, M P Rosen, A Baum, et al.
Pageof 22